Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2025 | 09-2024 | 03-2024 | 09-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,273 | 29,498 | 8,862 | 5,285 | 12,955 |
| Marketable Securities | N/A | 0 | 2,528 | 0 | 13,315 |
| Receivables | 13,526 | 18,572 | 14,384 | 12,997 | 17,519 |
| Inventories | 3,566 | 1,737 | 3,386 | 3,343 | 2,868 |
| Other current assets | 622 | 1,831 | 4,370 | 3,645 | 5,858 |
| TOTAL | $65,026 | $51,638 | $33,530 | $25,270 | $52,515 |
| Non-Current Assets | |||||
| PPE Net | 3,289 | 10,233 | 9,883 | 9,750 | 10,314 |
| Investments And Advances | 689 | 712 | 692 | 685 | 728 |
| Intangibles | 267 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,397 | 12,035 | 11,686 | 12,092 | 12,981 |
| TOTAL | $15,642 | $22,980 | $22,261 | $22,527 | $24,023 |
| Total Assets | $80,667 | $67,953 | $49,431 | $41,724 | $70,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,664 | 5,857 | 4,432 | 5,482 | 4,077 |
| Accounts payable and accrued liabilities | 15,986 | 4,915 | 7,764 | 4,585 | 11,239 |
| Accrued Expenses | 1,646 | 1,620 | 2,726 | 2,712 | 2,157 |
| Other current liabilities | N/A | 6,901 | 5,515 | 540 | 5,443 |
| TOTAL | $23,415 | $20,313 | $20,610 | $13,754 | $23,242 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,067 | 2,137 | 2,077 | 0 | N/A |
| TOTAL | $2,067 | $2,137 | $2,077 | $N/A | $N/A |
| Total Liabilities | $25,482 | $22,450 | $22,687 | $13,754 | $23,242 |
| Shareholders' Equity | |||||
| Common Shares | 6,338 | 482 | 68 | 68 | 68 |
| Retained earnings | -13,456 | -10,172 | -2,942 | -1,444 | 15,607 |
| Other shareholders' equity | -706 | 1,328 | 339 | 67 | 2,173 |
| TOTAL | $55,185 | $45,503 | $26,744 | $27,970 | $47,127 |
| Total Liabilities And Equity | $80,667 | $67,953 | $49,431 | $41,724 | $70,369 |